资讯

Investing.com - 富国银行(Wells Fargo)周二将Arcturus Therapeutics(NASDAQ:ARCT)的目标价从45.00美元下调至42.00美元,同时维持对该股的"增持"评级。这家市值3.09亿美元的生物技术公司显示出显著的价格波动性,贝塔系数为2.26。根据InvestingPro分析,该股票在当前水平下显得被低估。 研究机构表示,在Arcturus公布2 ...
WASHINGTON, July 31 (Xinhua) -- The U.S. Federal Reserve has kept its benchmark interest rate unchanged at 4.25 percent to 4.5 percent despite pressure from the White House to loosen monetary policy.